Exponential growth on the cards for the microbiome industry
Call to cut Indian child deaths from pneumonia and diarrhoea
Opioid-induced constipation – naloxegol
Inflammatory bowel disease – vedolizumab
Drug approvals: more numerous but niche
Irritable bowel syndrome – linaclotide
Short bowel syndrome – teduglutide
Gastroparesis – ulimorelin